COMPANY MISSION:
EMPOWER PATIENTS TO BREATHE

We all breathe 20.000 times a day and often take it for granted. Mechanically ventilated patients in critical care have impaired breathing activity, which can lead to severe consequences.

The core breathing muscle – the diaphragm - is lost by up to 50% in 18-69 hours.1
Lack of breathing function & muscle is the root cause of prolonged ventilation & ICU complications.2,3
STIMIT has developed non-invasive diaphragm stimulation technology designed to re-activate breathing in respiratory & critical care.  

Intensive Care Today


Machine forces air into lung

Can create lung injury
Diaphragm inactive:
loss of breathing muscles 

Critical Care Tomorrow



STIM IT, DON’T LOSE IT

diaphragm stimulation may have potential benefits for the lung (pressure distribution), the heart (blood return) and the brain4 

ACTIVATE THE DIAPHRAGM

Watch this video to learn about the importance of non-invasive diaphragm stimulation

VISION

REVOLUTIONIZING RESPIRATORY & CRITICAL CARE

the future critical care patient is active and mobile


EMPOWER PATIENTS TO BREATHE
creating natural breath instead of pumping air


References
1) Levine et al. 2008
2) Goligher et al. 2019
3) Morsy et al. 2015
4) Morris et al. 2022

Disclaimer

The company STIMIT currently has no approved product neither in the United States nor in Canada nor in Europe nor in any other region. All products and therapies are still in development and any statement arises from rationales or pre-clinical investigations which have yet to be completed.

STIMIT AG 

Aarbergstrasse 46
CH-2503 Biel/Bienne
Switzerland

Contact

Email: info@stimit.com
Tel: +41 32 513 93 00

Contact Us